TriSalus Life Sciences, Inc. TLSI Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s accrued expenses?
- TriSalus Life Sciences, Inc. (TLSI) reported accrued expenses of $269K in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s accrued expenses changed year-over-year?
- TriSalus Life Sciences, Inc.'s accrued expenses decreased by 36.9% year-over-year, from $426K to $269K.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s accrued expenses?
- Over 4 years (2020 to 2025), TriSalus Life Sciences, Inc.'s accrued expenses has grown at a 22.7% compound annual growth rate (CAGR), from $103.22K to $234K.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.